The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Carter Bruce L A | Director | Grant(A) | 20K | — | $0 |
| Mar 11, 2026 | Foletta Mark G | Director | Grant(A) | 20K | — | $0 |
| Mar 11, 2026 | Hata Yujiro S | Director | Grant(A) | 20K | — | $0 |
| Mar 11, 2026 | Peterson Kristine | Director | Grant(A) | 20K | — | $0 |
| Mar 11, 2026 | Russell Lesley | Director | Grant(A) | 20K | — | $0 |
| Mar 11, 2026 | Vance Terry | Director | Grant(A) | 20K | — | $0 |
| Feb 12, 2026 | Luly Jay R. | President and CEO, Director | Grant(A) | 5K | — | $0 |
| Feb 12, 2026 | Luly Jay R. | President and CEO, Director | Grant(A) | 15K | — | $0 |
| Feb 12, 2026 | Luly Jay R. | President and CEO, Director | Tax withholding(F) | 6K | $14.25 | $88K |
| Feb 12, 2026 | Or Yat Sun | Chief Scientific Officer | Grant(A) | 5K | — | $0 |
| Feb 12, 2026 | Or Yat Sun | Chief Scientific Officer | Grant(A) | 2K | — | $0 |
| Feb 12, 2026 | Or Yat Sun | Chief Scientific Officer | Tax withholding(F) | 3K | $14.25 | $49K |
| Feb 12, 2026 | Rottinghaus Scott T. | Chief Medical Officer | Grant(A) | 5K | — | $0 |
| Feb 12, 2026 | Rottinghaus Scott T. | Chief Medical Officer | Tax withholding(F) | 3K | $14.25 | $49K |
| Feb 12, 2026 | Rottinghaus Scott T. | Chief Medical Officer | Grant(A) | 2K | — | $0 |
| Feb 12, 2026 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax withholding(F) | 3K | $14.25 | $46K |
| Feb 12, 2026 | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant(A) | 5K | — | $0 |
| Feb 12, 2026 | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant(A) | 2K | — | $0 |
| Feb 12, 2026 | Luu Brendan | Chief Business Officer | Tax withholding(F) | 3K | $14.25 | $46K |
| Feb 12, 2026 | Luu Brendan | Chief Business Officer | Grant(A) | 2K | — | $0 |
| Feb 12, 2026 | Luu Brendan | Chief Business Officer | Grant(A) | 5K | — | $0 |
| Feb 12, 2026 | Kowalsky Matthew Paul | Chief Legal Officer | Grant(A) | 4K | — | $0 |
| Feb 12, 2026 | Kowalsky Matthew Paul | Chief Legal Officer | Grant(A) | 1K | — | $0 |
| Feb 12, 2026 | Kowalsky Matthew Paul | Chief Legal Officer | Tax withholding(F) | 2K | $14.25 | $27K |
| Dec 5, 2025 | Luly Jay R. | President and CEO, Director | Sell(S) | 5K | $14.23 | $67K |
| Dec 5, 2025 | Or Yat Sun | Chief Scientific Officer | Sell(S) | 2K | $14.23 | $34K |
| Dec 5, 2025 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell(S) | 2K | $14.23 | $30K |
| Dec 5, 2025 | Luu Brendan | Chief Business Officer | Sell(S) | 1K | $14.23 | $20K |
| Dec 5, 2025 | Rottinghaus Scott T. | Chief Medical Officer | Sell(S) | 798 | $14.23 | $11K |
| Dec 5, 2025 | Trout Harry R. III | See Remarks | Sell(S) | 542 | $14.23 | $8K |
| Dec 5, 2025 | Capps Kathleen S. | See Remarks | Sell(S) | 323 | $14.23 | $5K |
| Dec 2, 2025 | Trout Harry R. III | See Remarks | Sell(S) | 380 | $13.96 | $5K |
| Dec 2, 2025 | Capps Kathleen S. | See Remarks | Sell(S) | 207 | $13.96 | $3K |
| Dec 1, 2025 | Luly Jay R. | President and CEO, Director | Tax withholding(F) | 2K | $14.12 | $27K |
| Dec 1, 2025 | Or Yat Sun | Chief Scientific Officer | Tax withholding(F) | 753 | $14.12 | $11K |
| Dec 1, 2025 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax withholding(F) | 753 | $14.12 | $11K |
| Dec 1, 2025 | Luu Brendan | Chief Business Officer | Tax withholding(F) | 498 | $14.12 | $7K |
| Dec 1, 2025 | Trout Harry R. III | See Remarks | Tax withholding(F) | 105 | $14.12 | $1K |
| Dec 1, 2025 | Capps Kathleen S. | See Remarks | Tax withholding(F) | 85 | $14.12 | $1K |
| Nov 25, 2025 | Luly Jay R. | President and CEO, Director | Grant(A) | 310K | — | $0 |
| Nov 25, 2025 | Or Yat Sun | Chief Scientific Officer | Grant(A) | 110K | — | $0 |
| Nov 25, 2025 | Rottinghaus Scott T. | Chief Medical Officer | Grant(A) | 110K | — | $0 |
| Nov 25, 2025 | Kowalsky Matthew Paul | Chief Legal Officer | Grant(A) | 90K | — | $0 |
| Nov 25, 2025 | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant(A) | 100K | — | $0 |
| Nov 25, 2025 | Luu Brendan | Chief Business Officer | Grant(A) | 90K | — | $0 |
| Nov 25, 2025 | Trout Harry R. III | See Remarks | Grant(A) | 6K | — | $0 |
| Nov 25, 2025 | Trout Harry R. III | See Remarks | Grant(A) | 13K | — | $0 |
| Nov 25, 2025 | Capps Kathleen S. | See Remarks | Grant(A) | 3K | — | $0 |
| Nov 25, 2025 | Capps Kathleen S. | See Remarks | Grant(A) | 6K | — | $0 |
| Aug 8, 2025 | Rottinghaus Scott T. | Chief Medical Officer | Tax withholding(F) | 2K | $6.99 | $15K |
| Mar 13, 2025 | Carter Bruce L A | Director | Grant(A) | 16K | — | $0 |
| Mar 13, 2025 | Foletta Mark G | Director | Grant(A) | 16K | — | $0 |
| Mar 13, 2025 | Hata Yujiro S | Director | Grant(A) | 16K | — | $0 |
| Mar 13, 2025 | Peterson Kristine | Director | Grant(A) | 16K | — | $0 |
| Mar 13, 2025 | Russell Lesley | Director | Grant(A) | 16K | — | $0 |
| Mar 13, 2025 | Vance Terry | Director | Grant(A) | 16K | — | $0 |
| Feb 12, 2025 | Luly Jay R. | President and CEO, Director | Buy(P) | 45K | $5.69 | $256K |
| Feb 12, 2025 | Luly Jay R. | President and CEO, Director | Grant(A) | 26K | — | $0 |
| Feb 12, 2025 | Luly Jay R. | President and CEO, Director | Tax withholding(F) | 7K | $5.59 | $42K |
| Feb 12, 2025 | Mellett Paul J | Chief Fin. & Admin Officer | Tax withholding(F) | 3K | $5.59 | $19K |
| Feb 12, 2025 | Mellett Paul J | Chief Fin. & Admin Officer | Grant(A) | 8K | — | $0 |
| Feb 12, 2025 | Or Yat Sun | Chief Scientific Officer | Tax withholding(F) | 4K | $5.59 | $24K |
| Feb 12, 2025 | Or Yat Sun | Chief Scientific Officer | Grant(A) | 10K | — | $0 |
| Feb 12, 2025 | Rottinghaus Scott T. | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Feb 12, 2025 | Rottinghaus Scott T. | Chief Medical Officer | Tax withholding(F) | 3K | $5.59 | $16K |
| Feb 12, 2025 | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant(A) | 8K | — | $0 |
| Feb 12, 2025 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax withholding(F) | 3K | $5.59 | $19K |
| Feb 12, 2025 | Luu Brendan | Chief Business Officer | Grant(A) | 8K | — | $0 |
| Feb 12, 2025 | Luu Brendan | Chief Business Officer | Tax withholding(F) | 3K | $5.59 | $19K |
| Dec 6, 2024 | Luly Jay R. | President and CEO, Director | Sell(S) | 5K | $8.06 | $41K |
| Dec 6, 2024 | Mellett Paul J | Chief Fin. & Admin Officer | Sell(S) | 3K | $8.06 | $21K |
| Dec 6, 2024 | Or Yat Sun | Chief Scientific Officer | Sell(S) | 3K | $8.06 | $21K |
| Dec 6, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Sell(S) | 866 | $8.06 | $7K |
| Dec 6, 2024 | Luu Brendan | Chief Business Officer | Sell(S) | 2K | $8.06 | $18K |
| Dec 6, 2024 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell(S) | 2K | $8.06 | $18K |
| Dec 1, 2024 | Luly Jay R. | President and CEO, Director | Tax withholding(F) | 4K | $8.60 | $33K |
| Dec 1, 2024 | Mellett Paul J | Chief Fin. & Admin Officer | Tax withholding(F) | 2K | $8.60 | $14K |
| Dec 1, 2024 | Or Yat Sun | Chief Scientific Officer | Tax withholding(F) | 2K | $8.60 | $14K |
| Dec 1, 2024 | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax withholding(F) | 753 | $8.60 | $6K |
| Dec 1, 2024 | Luu Brendan | Chief Business Officer | Tax withholding(F) | 753 | $8.60 | $6K |
| Nov 27, 2024 | Luly Jay R. | President and CEO, Director | Grant(A) | 250K | — | $0 |
| Nov 27, 2024 | Mellett Paul J | Chief Fin. & Admin Officer | Grant(A) | 81K | — | $0 |
| Nov 27, 2024 | Or Yat Sun | Chief Scientific Officer | Grant(A) | 87K | — | $0 |
| Nov 27, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Grant(A) | 87K | — | $0 |
| Nov 27, 2024 | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant(A) | 81K | — | $0 |
| Nov 27, 2024 | Luu Brendan | Chief Business Officer | Grant(A) | 75K | — | $0 |
| Nov 27, 2024 | Kowalsky Matthew Paul | Chief Legal Officer | Grant(A) | 75K | — | $0 |
| Aug 8, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Tax withholding(F) | 1K | $12.73 | $19K |
| Jul 15, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Sell(S) | 5K | $17.08 | $92K |
| Jul 15, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Option exercise(M) | 5K | $8.99 | $48K |
| Jul 15, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Jul 12, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Sell(S) | 2K | $15.04 | $34K |
| Jul 11, 2024 | Rottinghaus Scott T. | Chief Medical Officer | Sell(S) | 4K | $15.07 | $65K |
| Jun 17, 2024 | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell(S) | 7K | $12.33 | $90K |
| Apr 29, 2024 | Kowalsky Matthew Paul | Chief Legal Officer | Grant(A) | 150K | — | $0 |
| Mar 6, 2024 | Carter Bruce L A | Director | Grant(A) | 16K | — | $0 |
| Mar 6, 2024 | Foletta Mark G | Director | Grant(A) | 16K | — | $0 |
| Mar 6, 2024 | Hata Yujiro S | Director | Grant(A) | 16K | — | $0 |
| Mar 6, 2024 | Peterson Kristine | Director | Grant(A) | 16K | — | $0 |
| Mar 6, 2024 | Russell Lesley | Director | Grant(A) | 16K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).